Abstract
To date, sulfonylurea derivatives occupy a leading position in the structure of diabetes mellitus therapy. The article discusses the effectiveness and safety of the use of sulfonylurea derivatives in order to compensate for carbohydrate metabolism, including in comparison with other classes of hypoglycemic drugs. Special emphasis is placed on cardiovascular safety.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
